166 related articles for article (PubMed ID: 1533782)
1. Current approaches to the management of fungal infections in cancer patients: Part 1.
Francis P; Walsh TJ
Oncology (Williston Park); 1992 Apr; 6(4):81-92; discussion 97-100. PubMed ID: 1533782
[TBL] [Abstract][Full Text] [Related]
2. [Fungal infections in children with malignant disease].
Michel G
Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections associated with malignancies, treatments, and AIDS.
Benedict S; Colagreco J
Cancer Nurs; 1994 Oct; 17(5):411-7. PubMed ID: 7954389
[TBL] [Abstract][Full Text] [Related]
4. Treatment of fungal infections in patients infected with the human immunodeficiency virus.
Sugar AM
Pharmacotherapy; 1990; 10(6 ( Pt 3)):154S-158S. PubMed ID: 2075115
[TBL] [Abstract][Full Text] [Related]
5. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
6. [Candida infections in immunocompromised hosts].
Wasak-Szulkowska E
Pol Merkur Lekarski; 2005 Jul; 19(109):5-9. PubMed ID: 16194017
[TBL] [Abstract][Full Text] [Related]
7. Fungal infections in cancer patients: an escalating problem.
Samonis G; Bafaloukos D
In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
[TBL] [Abstract][Full Text] [Related]
8. Emerging disease issues and fungal pathogens associated with HIV infection.
Ampel NM
Emerg Infect Dis; 1996; 2(2):109-16. PubMed ID: 8903210
[TBL] [Abstract][Full Text] [Related]
9. [AIDS and opportunistic visceral mycoses. A diagnostic and therapeutic update].
Manfredi R
Recenti Prog Med; 1998 Dec; 89(12):657-67. PubMed ID: 9951317
[TBL] [Abstract][Full Text] [Related]
10. [Systemic fungal infections in immunocompromised patients].
Zupanić-Krmek D; Nemet D
Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
[TBL] [Abstract][Full Text] [Related]
11. Fungal infections in AIDS patients.
Stevens DA
Br J Clin Pract Suppl; 1990 Sep; 71():11-22. PubMed ID: 2091732
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of infections caused by opportunistic agents: fungi].
Martín E; Nogales MC; Flórez C; Vargas J; Sánchez A
Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():62-6. PubMed ID: 2490490
[No Abstract] [Full Text] [Related]
13. Systemic fungal infections: major problems in cancer patients.
Powles RL; Mehta J
Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of systemic mycoses in immunodeficiency].
Just-Nübling G; Stille W
Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
[TBL] [Abstract][Full Text] [Related]
15. The challenge of invasive fungal infection.
de Pauw BE; Meunier F
Chemotherapy; 1999 Jun; 45 Suppl 1():1-14. PubMed ID: 10394016
[TBL] [Abstract][Full Text] [Related]
16. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
17. Treatment of fungal and other opportunistic infections in immunocompromised patients.
Wade JC
Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
[TBL] [Abstract][Full Text] [Related]
18. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
19. Fungal infections in the immunocompromised host.
Hawkins C; Armstrong D
Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcal lung disease.
Shirley RM; Baddley JW
Curr Opin Pulm Med; 2009 May; 15(3):254-60. PubMed ID: 19352182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
